Evogene Ltd.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles about it in the 4Search index. Click a dot on the chart for the event and the news of that day.
Key statistics
Against its peers
Compare in full ›| EVGN.TA | EDSA | EVMN | EVAX | CVM | CANF | |
|---|---|---|---|---|---|---|
| Market cap | 17.96M | 27.02M | 291.10M | 20.75M | 21.28M | 4.35M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -0.3 | — | -2.1 | -150.0 | -0.2 | -1.6 |
| Price/book | -4.1 | 48.8 | 1.0 | 2.0 | 1.9 | 0.6 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −70.81% | +14.94% | −61.30% | −60.81% | −76.52% | −74.66% |
| Today | −3.30% | −8.05% | −2.76% | +10.84% | −17.69% | −2.34% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All EVGN.TA news ›Evogene quarterly loss widens to $2.86 million
Key points Evogene (NASDAQ:EVGN) reported a third-quarter 2026 net loss of US$2.862 million, compared with net income of US$5.197 million a year earlier. Quarterly revenue fell to US$141,000 from US$312,000, while nine-month revenue…
Evogene Targets Acute GVHD With New AI-Driven Drug Discovery Program
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.
Evogene GAAP EPS of -$0.17 beats by $0.02, revenue of $0.14M misses by $0.22M
Evogene reports Q3 GAAP EPS of -$0.17, beating estimates by $0.02, while revenue fell 54.8% year over year to $0.14M, missing estimates by $0.22M. Evogene GAAP EPS of -$0.17 beats by $0.02, revenue of $0.14M misses by $0.22M - Evogene…
Evogene (EVGN) Q3 2026 Earnings Call Transcript
Bayer agreement expiry and warrant costs weighed on results as new AI-designed candidates advanced. Image source: The Motley Fool. DATE CALL PARTICIPANTS Chairman of the Board of Directors - Nir Nimrodi President and CEO - Ofer Haviv VP…
Evogene: Q3 Earnings Snapshot
On a per-share basis, the Rehovot, Israel-based company said it had a loss of 17 cents. The agricultural company posted revenue of $141,000 in the period.
Evogene Wins Nasdaq Extension to March 2027 to Fix Minimum Bid Price
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.
Evogene Reports Financial Results for the Third Quarter and First Nine Months of 2026, Highlighting Progress in Two Internal Development Programs
News provided by Company advances its internally developed drug discovery program targeting acute graft-versus-host disease (aGVHD) and AgPlenus' fungicide discovery programs targeting novel MoA against Septoria REHOVOT, Israel,…
Evogene Ltd. Appoints Adi Zuluf-Shani as Chairperson of Board, as of November 18, 2026
Evogene Ltd. announced its Board of Directors has appointed Dr. Adi Zuluf-Shani as Chairperson of the Board, as of November 18, 2026. Evogene Ltd. Appoints Adi Zuluf-Shani as Chairperson of Board, as of November 18, 2026 Evogene Ltd.…
Agplenus Ltd. and Evogene Ltd. Announce Progress in Fungicide Discovery Programs Targeting New Modes of Action
AgPlenus Ltd., a developer of novel crop-protection products and a subsidiary of Evogene Ltd. announced significant progress in two fungicide discovery programs targeting novel modes of action against... Agplenus Ltd. and Evogene Ltd.…
Evogene Announces the Appointment of Nir Nimrodi as the New Chairperson of the Board, Effective March 5, 2025
News provided by Mr. Nir Nirmodi is Replacing Ms. Sarit Firon, who will Continue Serving as a Member of the Board REHOVOT, Israel, /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company aiming to…
From the 4Search news index, newest first.
In the news
People in the coverage
Themes
Most coverage from
- marketscreener.com16
- prnewswire.com5
- aol.com2
- seekingalpha.com2
- theglobeandmail.com2
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 32 articles, not a forecast.